Form4.ai tracks every SEC insider trade in real time. See every RNA insider filing with a free account — no card.
See every RNA insider filing — free account, no card.
Free accountAtrium Therapeutics, Inc. (RNA) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 22, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 22, 2026 SEC filing | Younis Husam Chief Scientific Officer | Tax withholding | $100,383 | — |
| Sep 22, 2026 SEC filing | Hughes Steven George Chief Medical Officer | Tax withholding | $192,058 | — |
| Sep 22, 2026 SEC filing | Flanagan W. Michael Director | Tax withholding | $204,167 | — |
Create a free account to see all 8 RNA filings from the last 90 days. No card needed.
Create free accountWant RNA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.